Mcdaniel Terry & Co. Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mcdaniel Terry & Co. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 70,499 shares of the medical equipment provider’s stock after acquiring an additional 334 shares during the quarter. Intuitive Surgical accounts for 3.0% of Mcdaniel Terry & Co.’s holdings, making the stock its 12th biggest position. Mcdaniel Terry & Co.’s holdings in Intuitive Surgical were worth $36,798,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the fourth quarter valued at $82,517,000. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC grew its position in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.3 %

NASDAQ:ISRG opened at $608.48 on Thursday. The company’s 50-day moving average price is $563.17 and its 200-day moving average price is $522.88. The company has a market cap of $216.73 billion, a P/E ratio of 94.93, a P/E/G ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 over the last ninety days. Company insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several analyst reports. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Finally, Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.